摘要:
The present invention provides a compound, a photoelectric converter and a photoelectrochemical cell. The complex compound (I) is obtained by coordinating a ligand represented by the formula (II) and a ligand represented by the formula (III) to a metal atom, wherein Y1 and Y2 each independently represent a group including an unsaturated hydrocarbon group and an aromatic ring, R1 and R2 each independently represent a protogenic group or a salt thereof, at least one of R1 and R2 is a protogenic group, R3 and R4 each independently represent an aprotogenic group, R3 and R4 may be bound together, A and B each independently represent a group including an element of group 14, 15, or 16 of the Periodic Table, m and n each independently represent an integer of 0 to 2, a, b, c, and d each independently represent an integer of 0 to 2, and a+b≧1.
摘要:
The present invention relates to luminescent compounds having a functionalised linker arm, their synthesis and use in bioconjugation and labelling of biomolecules, such as for example nucleosides, nucleotides, nucleic acids (DNA, RNA or PNA) and proteins, as well as their use in the execution of in vitro and in vivo analytic and diagnostic assays.
摘要:
A new class of ligands derived from benzo[h]quinoline are described and these ligands are used to prepare several novel transition metal complexes. The complexes are preferably of the group VIII transition metals iron, ruthenium or osmium, with the benzo[h]quinoline ligands acting as tridentate ligands. The complexes described are proved to be very active catalysts for the reduction of ketones and aldehydes to alcohols, via hydrogen transfer and hydrogenation reactions. These compounds hence can be usefully employed as catalysts in said reduction reactions.
摘要:
A complex compound (I) obtained by coordinating a compound represented by the following formula (II), hereinafter abbreviated as compound (II), to a metal atom. In the formula, R1, R2 and R3 each independently represent a substituent represented by the following formula (III), formula (IV), formula (V) or formula (VI) and at least one of them is a substituent represented by the formula (III); a, b and c each independently represent an integer of 0 to 2 and a+b+c≧1; here, L represents a linking group represented by the following formula (VII) or formula (VIII); Ar represents an aryl group which may have a substituent; A represents an acidic group or a salt thereof; Y represents a halogen atom or a substituent; Q1 and Q2 each independently represent a hydrogen atom, an alkyl group having 1 to 20 carbon atoms, an alkoxy group having 1 to 20 carbon atoms, an aryl group having 6 to 20 carbon atoms or a cyano group; and p and q each represent an integer of 1 to 3.
摘要:
The invention relates to novel organo phosphorus P-chiral optically active compounds of formula (I) having a hydroxyl, mercapto, amino, carboxyl, sulfonyl group on aryl near a phosphorus atom, to the preparation and the use thereof in then asymmetrical catalysis of unsaturated compounds. Novel acylphosphine optically pure ligands embodied in the form of transition metal complexes exhibit an increased activity and enantloselectivity, in particular in asymmetrical hydrogenation, in comparison with the same type Uganda such as DiPAMP.
摘要:
The present invention relates to a ruthenium-type dye and a making method thereof, and more particularly, to a ruthenium-type dye which is used to manufacture a dye-sensitized solar cell, drastically improves a molar extinction coefficient to enhance efficiency of a solar cell with only a small amount of a dye and oxide semiconductor particles, allows a thin film solar cell element to be manufactured without difficulty and sharply reduces manufacturing costs of a solar cell, and a making method thereof.
摘要:
This inventive subject matter relates to novel metal complex protein kinases inhibitors, methods for making such compounds, and methods for using such compounds for treating diseases and disorders mediated by kinase activity.
摘要:
Disclosed is a process for production of an asymmetric binuclear metal complex represented by the general formula: (L1)2M1(BL)M2(L2)2(X)n wherein M1 and M2, which may be the same as or different from each other, represent a transition metal; L1 and L2, which are different from each other, represent a chelate ligand capable of multidentate coordination and two L1s may be different from each other and two L2s may be different from each other; BL represents a bridging ligand having at least two cyclic structures each containing a hetero atom, the hetero atoms contained in the cyclic structures being ligand atoms coordinating to M1 and M2; X represents a counter ion; and n is the number of counter ions needed to neutralize the charge of the complex. In the process, the binuclear metal complex is isolated by adjusting the pH of the solution containing the binuclear metal complex to a value higher than 2.5. The binuclear metal complex obtained may be used as a dye to produce a photoelectric conversion element and a photochemical battery having higher photoelectric conversion efficiency and higher durability.
摘要:
The invention relates to a new class of ruthenium (II) complexes containing as ligands 2-(aminomethyl)pyridines and phosphines, proven to be extremely active catalysts in the reduction of ketones to alcohols via hydrogen transfer. By using 2-propanol as the hydrogen source with the ruthenium complexes, high yields of the corresponding alcohol can be rapidly obtained starting from linear and cyclic alkyl aryl, dialkyl and diaryl ketones. The conversion of ketones to alcohols can reach 100% if operating in a gaseous hydrogen atmosphere (2-3 atm). Where the phosphines used are optically active, starting from prochiral ketone compounds various types of optically active alcohols can be produced, being important intermediates in the pharmaceutical industry, in the agrochemical industry and for fine chemicals generally.